deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03441789

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Sponsor: L.H. Kircik, M.D.

Conditions Plaque Psoriasis
Interventions Enstilar Otezla Vehicle
Updated 6 times since 2018 Last updated: Mar 12, 2019 Started: Sep 18, 2017 Primary completion: Oct 1, 2018 Completion: Oct 22, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Plaque Psoriasis and is currently completed. L.H. Kircik, M.D. leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotRecruiting~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Apr 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE4

▶ Show 1 earlier version

  1. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • L.H. Kircik, M.D.
Data source: Derm Research, PLLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations